HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

motavizumab (Numax)

is a MAb derived from palivizumab with enhanced neutralizing activity against RSV
Also Known As:
Numax; MEDI-524
Networked: 20 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Losonsky, Genevieve A: 5 articles (12/2015 - 04/2009)
2. Griffin, M Pamela: 3 articles (12/2015 - 08/2011)
3. Harris, Brian S: 3 articles (12/2015 - 08/2011)
4. Jensen, Kathryn M: 3 articles (12/2015 - 08/2011)
5. Motavizumab Study Group: 3 articles (07/2014 - 04/2009)
6. Karron, Ruth A: 2 articles (12/2016 - 12/2015)
7. O'Brien, Katherine L: 2 articles (12/2016 - 12/2015)
8. Santosham, Mathuram: 2 articles (12/2016 - 12/2015)
9. Simões, Eric A F: 2 articles (01/2016 - 01/2010)
10. Jafri, Hasan S: 2 articles (12/2015 - 11/2005)

Related Diseases

1. Respiratory Syncytial Virus Infections
2. Respiratory Tract Infections (Respiratory Tract Infection)
3. Hypercatabolic Hypoproteinemia
4. Respiratory Sounds (Crackle)
5. Lung Diseases (Lung Disease)

Related Drugs and Biologics

1. Palivizumab
2. Monoclonal Antibodies
3. Immunoglobulin G (IgG)
4. Immunoglobulin A (IgA)
5. nirsevimab
6. Neutralizing Antibodies
7. Intravenous Immunoglobulins (IVIG)
8. Biomarkers (Surrogate Marker)
9. Vaccines
10. Ribavirin (Virazole)

Related Therapies and Procedures

1. Bone Marrow Transplantation (Transplantation, Bone Marrow)